Antioxidant botanicals and antimicrobial defenses/Kevin Fritsche
Antioxidant botanicals and antimicrobial defenses/Kevin Fritsche
批准号:
8007166
负责人:
DENNIS B LUBAHN
金额:
$34.51万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-01 至 2011-06-30
关键词:
AffectAnimalsAnti-Bacterial AgentsAnti-Inflammatory AgentsAnti-inflammatoryAntioxidantsAntiviral ResponseBacterial InfectionsBiological MarkersBotanicalsCCL2 geneCell LineCellsClinical TrialsCrude ExtractsDesire for foodEatingElderberryEscherichia coliEventFeverFigs - dietaryGene ExpressionGenerationsGeneticHIVHIV InfectionsHealthHost resistanceHumanImmuneImmune responseImmune systemIn VitroInfectionInflammationInflammatoryInflammatory ResponseInterleukin-10Interleukin-12Interleukin-6ListeriosisMediatingModelingMonitorMusMyelogenousMyeloid CellsNADPH OxidaseNatural ImmunityOpportunistic InfectionsOutcomeOxidation-ReductionPathway interactionsPatientsPhagocytesResistanceScreening procedureSepsisShapesSignal PathwaySignal TransductionSymptomsTestingViralViral PhysiologyWorkantimicrobialclinically relevantexperiencefoodbornehuman NOS2A proteinimprovedin vivomacrophagemouse modelnovelpathogenpre-clinicalresponse
中文摘要
这个项目的主要目的是对选定的抗氧化剂植物药物进行临床前筛选
在体内调节抗微生物和抗病毒活性的潜力。粗提物和推定的生物活性
每种植物的成分都将在体内和体外进行测试。两种小鼠细菌感染模型
(即共同//介导性脓毒症和系统性李斯特菌病)和一种新的小鼠艾滋病毒模型。临床上
将监测相关结果,如发烧、进食、嗜睡和细菌/病毒清除。
具有一组共同的炎症/感染生物标志物(例如,肿瘤坏死因子-α、白介素IP、白介素6、单核细胞趋化蛋白-1、白介素12、白介素10)。这个
工作假说是,具有强大抗氧化活性的植物性物质会影响宿主的氧化还原状态
吞噬细胞,使炎症、抗细菌和抗病毒反应发生改变。结果就是
在这种改变的细胞氧化还原过程中,宿主将体验到明显的好处(例如,低烧、增强
病原体清除,减少全身炎症)。令人兴奋和新奇的初步发现表明
紫苏木和接骨木提取物影响细菌清除和在大肠杆菌败血症模型中的存活。一个
小鼠巨噬细胞系RAW 264.7细胞将被用于描述细胞事件的变化
对炎症、抗细菌和抗病毒途径在植物学反应中的重要性
化合物包括:NADPH氧化酶(NOX)和诱导型一氧化氮合酶(INOS)活性,核因子-KB
激活和Nri‘2-Keap1信号转导。此外,在细胞中有条件删除Keapl的小鼠
髓系(即吞噬细胞)将被用来评估Nrf2依赖基因之间的相互作用
植物抗氧化剂在影响宿主对感染反应中的表达。患有髓系特异性白血病的小鼠
Keap1的缺失应该大大增强了吞噬细胞中的Nri‘2信号,从而使体内的氧化还原状态
这些先天免疫细胞被改变,导致炎症减轻。这些独特的老鼠将被用来
吞噬细胞中Nrf2信号的相互作用及不同植物药对先天感染的影响
免疫系统和宿主对感染的反应。
英文摘要
The primary aim ofthis project is to conduct pre-clinical screening of selected antioxidant botanicals for their
potential to modulate in vivo anti-microbial and anti-viral activity. Crude extracts as well as putative bioactive
components of each botanical will be tested both in vivo and in vitro. Two murine bacterial infection models
(i.e., ¿ co//-mediated sepsis and systemic listeriosis) and a novel murine HIV model will be used. Clinically
relevant outcomes, such as fever, food intake, lethargy, and bacterial/viral clearance will be monitored along
with a common set of inflammation/infection biomarkers (e.g., TNF-a, IL-ip, IL-6, MCP-1, IL-12, IL-10). The
working hypothesis is that botanicals with potent antioxidant activity will affect the redox status of host
phagocytes such that inflammatory, anti-bacterial and anti-viral responses will be altered. As a consequence
of this altered cellular redox the host will experience discernable benefits (e.g., lower fever, enhanced
pathogen clearance, reduced systemic inflammation). Exciting and novel preliminary findings show that
Sutheriandia and elderberry extracts affect bacterial clearance and survival in the ¿ coli sepsis model. A
murine macrophage cell line, RAW 264.7 cells, will be used to profile alterations in cellular events of
importance to the inflammatory, anti-bacterial, and anti-viral pathways in response to the botanical
compounds including: NADPH oxidase (NOX) and inducible nitric oxide synthase (INOS) activity, NF-KB
activation and Nri'2-Keapl signaling. Additionally, mice with a conditional deletion of Keapl in cells from the
myeloid lineage (i.e., phagocytes) will be used to evaluate the interaction between Nrf2-dependent gene
expression and antioxidant botanicals in shaping host response to infection. Mice with a myeloid-specific
deletion of Keapl should have greatly enhanced Nri'2 signaling in phagocytes such that redox status within
these innate immune cells is altered resulting in diminished inflammation. These unique mice will be used to
explore interactions between Nrf2 signaling in phagocytes and effects of various botanicals on the innate
immune system and the host response to infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mu Center for Botanical Interaction Studies
-
批准号:8722446
-
项目类别:
-
资助金额:$142.17万
-
财政年份:2010
-
负责人:DENNIS B LUBAHN
-
依托单位:
Mu Center for Botanical Interaction Studies
-
批准号:8326556
-
项目类别:
-
资助金额:$146.59万
-
财政年份:2010
-
负责人:DENNIS B LUBAHN
-
依托单位:
Mu Center for Botanical Interaction Studies
-
批准号:8136301
-
项目类别:
-
资助金额:$145.05万
-
财政年份:2010
-
负责人:DENNIS B LUBAHN
-
依托单位:
Analytical Chemistry Core/George Rottinghaus
-
批准号:8007178
-
项目类别:
-
资助金额:$10.04万
-
财政年份:2010
-
负责人:DENNIS B LUBAHN
-
依托单位:
Nutrition/Animal Core/Kevin Fritsche
-
批准号:8007177
-
项目类别:
-
资助金额:$9.52万
-
财政年份:2010
-
负责人:DENNIS B LUBAHN
-
依托单位:
The Interactions Core/Mark Mcintosh
-
批准号:8007179
-
项目类别:
-
资助金额:$22.51万
-
财政年份:2010
-
负责人:DENNIS B LUBAHN
-
依托单位:
Botanicals Targeting 5 Signaling Pathways to prevent prostate cance/Dennis Lubahn
-
批准号:8007164
-
项目类别:
-
资助金额:$35.82万
-
财政年份:2010
-
负责人:DENNIS B LUBAHN
-
依托单位:
Mu Center for Botanical Interaction Studies
-
批准号:8509482
-
项目类别:
-
资助金额:$11.36万
-
财政年份:2010
-
负责人:DENNIS B LUBAHN
-
依托单位:
Botanical Phenolics on Oxidative/Nitrosative Signaling Pathways/Grace Sun
-
批准号:8007165
-
项目类别:
-
资助金额:$35.62万
-
财政年份:2010
-
负责人:DENNIS B LUBAHN
-
依托单位:
Botanical/Plant Genomics Core/Wendy Applequist
-
批准号:8007170
-
项目类别:
-
资助金额:$4.36万
-
财政年份:2010
-
负责人:DENNIS B LUBAHN
-
依托单位:
Mu Center for Botanical Interaction Studies
-
批准号:7998373
-
项目类别:
-
资助金额:$152.38万
-
财政年份:2010
-
负责人:DENNIS B LUBAHN
-
依托单位:
Mu Center for Botanical Interaction Studies
-
批准号:8540341
-
项目类别:
-
资助金额:$142.18万
-
财政年份:2010
-
负责人:DENNIS B LUBAHN
-
依托单位:
PROSTATE TUMOR PROGRESSION ALTERED BY PHYTO ESTROGENS
-
批准号:7601286
-
项目类别:
-
资助金额:$0.03万
-
财政年份:2007
-
负责人:DENNIS B LUBAHN
-
依托单位:
Phytoestrogen and Antioxidant Regulation of Prostate Cancer
-
批准号:7476576
-
项目类别:
-
资助金额:$28.11万
-
财政年份:2006
-
负责人:DENNIS B LUBAHN
-
依托单位:
Phytoestrogen and Antioxidant Regulation of Prostate Cancer
-
批准号:7678436
-
项目类别:
-
资助金额:$28.11万
-
财政年份:2006
-
负责人:DENNIS B LUBAHN
-
依托单位:
Phytoestrogen and Antioxidant Regulation of Prostate Cancer
-
批准号:7210249
-
项目类别:
-
资助金额:$29.54万
-
财政年份:2006
-
负责人:DENNIS B LUBAHN
-
依托单位:
Phytoestrogen and Antioxidant Regulation of Prostate Cancer
-
批准号:7289786
-
项目类别:
-
资助金额:$28.68万
-
财政年份:2006
-
负责人:DENNIS B LUBAHN
-
依托单位:
Prostate Tumor Progression altered by phyto estrogens.
-
批准号:6980081
-
项目类别:
-
资助金额:$0.11万
-
财政年份:2004
-
负责人:DENNIS B LUBAHN
-
依托单位:
PROSTATE TUMOR PROGRESSION ALTERED BY PHYTO ESTROGENS
-
批准号:7181640
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2004
-
负责人:DENNIS B LUBAHN
-
依托单位:
Do phytonutrients affect prostate tumor progression
-
批准号:6647789
-
项目类别:
-
资助金额:$6.54万
-
财政年份:2002
-
负责人:DENNIS B LUBAHN
-
依托单位:
海外基金